Photo of Nikolas Harbord

Nikolas Harbord

  • ASSISTANT PROFESSOR Medicine, Nephrology
Print ProfilePrint Profile


  • American Board of Internal Medicine


  • Residency, Mount Sinai Beth Israel

  • Fellowship, Mount Sinai Beth Israel

  • MD, Rutgers Medical School


    Dr. Harbord is a Specialist in Clinical Hypertension (ASH), with an interest in diabetic kidney disease, critical care nephrology and acute kidney injury, chronic kidney disease, edematous states, and electrolyte and acid-base disorders.

    Dr. Nikolas Harbord received his medical degree from the UMDNJ-Robert Wood Johnson Medical School (now Rutgers Medical School), and completed both his internal medicine residency and nephrology fellowship at Beth Israel Medical Center (now Mount Sinai Beth Israel). Dr. Harbord is board certified in internal medicine and nephrology. He has served as the program director for the nephrology fellowship since 2012, and as interim division chief since 2014.

    Dr. Harbord administers the division of nephrology and the nephrology fellowship program. He directs the weekly diabetic nephropathy clinic at the Friedman Diabetes Center. Dr. Harbord serves MSBI on the pharmacy and therapeutics committee and the Mount Sinai Health System on the Department of Medicine clinical trials review committee. He has published on various topics within nephrology, including nephrotoxicity and mineral bone disease. He was named a New York Rising Star in Nephrology in 2013 & 2014 by & NY Times Magazine. He maintains an active dialysis and office practice, and accepts new patients.


  • -
    American Registry- Patient's Choice, On Time, Most Compassionate Doctor

  • 2013, 2014 -
    New York Rising Stars- Nephrology & NY Times Magazine


I have helped to describe the association between bisphosphonate therapy and adynamic bone disease in CKD patients, by using dynamic bone labeling and bone histology. With my colleagues at MSBI, I have described the inflammation evident in ESRD patients with various types of hemodialysis access. As a co-investigator in an industry funded clinical trial [Multi-Center Study of the Effect of Sevelamer Carbonate on Metabolic/Inflammatory/Reactive Oxygen Species (ROS) in Diabetes with Nephropathy, the AGELESS study] at MSBI and Mount Sinai, I helped recruit study subjects and am involved in the current publication of our findings. I have also guided the comprehensive survey of the impact of Hurricane Sandy on hemodialysis patients in NYC; and will soon publish our findings. As the training program director and division chief (interim) for Nephrology & Hypertension at MSBI I will be responsible for promoting scholarly activity and research among all fellows and faculty.


Winchester JF, Harbord NB. Intoxications amenable to extracorporeal removal. Advances in chronic kidney disease 2011 May; 18(3).

Harbord N. Novel nephrotoxins. Advances in chronic kidney disease 2011 May; 18(3).

Harbord N, Amerling R. Fluid and electrolyte balance in tennis players. Nephrology news & issues 2011 Apr; 25(4).

Goldfarb DS, Harbord NB, Winchester JF. The hemodialysis machine: where the nephrologists and toxicologists meet. Advances in chronic kidney disease 2011 May; 18(3).

Charen E, Dadzie K, Sheth N, Siktel H, Dubrow A, Harbord N, Winchester J, Ronco C, Amerling R. Hepatorenal syndrome treated for eight months with continuous-flow peritoneal dialysis. Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2013; 29.

Amerling R, Harbord NB, Pullman J, Feinfeld DA. Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series. Blood purification 2010; 29(3).

Winchester JF, Harbord NB, Rosen H. Management of poisonings: core curriculum 2010. American journal of kidney diseases : the official journal of the National Kidney Foundation 2010 Oct; 56(4).

Winchester JF, Amerling R, Harbord N, Capponi V, Ronco C. The potential application of sorbents in peritoneal dialysis. Contributions to nephrology 2006; 150.

Brener ZZ, Harbord NB, Zhuravenko I, Nicastri AD, Bergman M, Dubrow A, Feinfeld D, Winchester J. Acute renal failure in a patient with West Nile viral encephalitis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007 Feb; 22(2).

Winchester JF, Harbord N, Audia P, Dubrow A, Gruber S, Feinfeld D, Amerling R. The 2006 K/DOQI guidelines for peritoneal dialysis adequacy are not adequate. Blood purification 2007; 25(1).

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Harbord did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Edit profile in Sinai Central


10 Union Square - PACC Room Suite 2F
10 Union Square
New York, NY 10003

Tel: 212-420-4070


350 East 17th St.
18th floor, #23
New York, NY 10003

Tel: 212-420-4070